Clinical trial of fusidic acid for lepromatous leprosy.

Fusidic acid was assessed for antileprosy activity in nine lepromatous leprosy patients. Patients received fusidic acid at either 500 mg/day for 12 weeks or 750 mg/day for 4 weeks followed by 500 mg/day for 8 weeks. All patients showed time-dependent clinical improvement and decreases in bacillary m...

Full description

Saved in:
Bibliographic Details
Main Authors: Franzblau, S G, Chan, G P, Garcia-Ignacio, B G, Chavez, V E, Livelo, J B, Jimenez, C L, Parrilla, M L, Calvo, R F, Williams, D L, Gillis, T P
Format: Artigo
Language:Inglês
Published: 1994
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC284609/
https://ncbi.nlm.nih.gov/pubmed/7979302
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items